IMEXF (Imagin Medical) Retained Earnings: $-25.04 Mil (As of Jun. 2023)


What is Imagin Medical Retained Earnings?

Imagin Medical IMEXF -99.00% Retained Earnings is $-25.04 Mil as of Jun. 2023.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Imagin Medical's retained earnings for the quarter that ended in Jun. 2023 was $-25.04 Mil.

Imagin Medical's quarterly retained earnings declined from Dec. 2022 ($-25.47 Mil) to Mar. 2023 ($-25.93 Mil) but then increased from Mar. 2023 ($-25.93 Mil) to Jun. 2023 ($-25.04 Mil).

Imagin Medical's annual retained earnings declined from Sep. 2020 ($-15.61 Mil) to Sep. 2021 ($-25.35 Mil) and declined from Sep. 2021 ($-25.35 Mil) to Sep. 2022 ($-25.95 Mil).

Imagin Medical  (OTCPK:IMEXF) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Imagin Medical Retained Earnings Historical Data

* Premium members only.

The historical data trend for Imagin Medical's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagin Medical Retained Earnings Chart

Imagin Medical Annual Data
Trend Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.07 -12.29 -15.61 -25.35 -25.95

Imagin Medical Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -23.39 -25.95 -25.47 -25.93 -25.04

Imagin Medical Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of $-25.04 Mil mean?
Imagin Medical (IMEXF) has a Retained Earnings of $-25.04 Mil as of Jun. 2023. Retained earnings is the amount of net income not issued to shareholders. View historical data on Imagin Medical and its competitors.
Is Imagin Medical's Retained Earnings too high?
Imagin Medical's current Retained Earnings is $-25.04 Mil.
How does Imagin Medical's Retained Earnings compare to ABT and SYK?
Imagin Medical's Retained Earnings of $-25.04 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Imagin Medical and its competitors. Imagin Medical's current Retained Earnings is $-25.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagin Medical stock overvalued right now?
Imagin Medical (IMEXF) has a current Retained Earnings of $-25.04 Mil. The current Retained Earnings is $-25.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Imagin Medical (IMEXF), the current Retained Earnings is $-25.04 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagin Medical Business Description

Address 890 West Pender Street, Suite 600, Vancouver, BC, CAN, V6C 1J9
Imagin Medical Inc is a Urologic Oncology company developing technologies to visualize and treat urologic cancers, including bladder and prostate cancer, through minimally invasive surgery. The company's first product, the i/Blue Imaging System, with its proprietary optics and light sensors, will greatly increase the efficiency and accuracy of detecting bladder cancer, helping to improve the surgical management of this disease. Imagin's follow-on product, the enCAGE Coil is a device with 510(k) clearance for soft tissue ablation. Imagin intends to refine the disposable bipolar radio frequency-based probe for use in the treatment of prostate cancer and benign prostate hypoplasia (BPH) and submit appropriate FDA premarket applications for the new indications.